The Macroaxis Fundamental Analysis lookup allows users to check a given indicator for any equity or select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please check also Equity Screeners
to view more equity screening tools
Price to Sales Analysis
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
| = |
MV Per Share
Revenue Per Share
| = |
About Price to Sales
The most important factor to remember is that the price of equity takes a firm's debt into account, whereas the sales does not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
Based on latest financial disclosure the price to sales indicator of Bharat Immunologicals Biologicals Corp Ltd is roughly 0.66 times. This is much higher than that of the sector, and significantly higher than that of Price to Sales industry, The Price to Sales for all stocks is over 1000% lower than the firm.
Bharat Immunologicals Fundamental Drivers Relationships
Bharat Immunologicals Biologicals Corp Ltd is rated below average
in profit margin category among related companies. It is rated below average
in cash and equivalents category among related companies .